ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,910Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 403

$660K Total Retail Price of All Prescriptions

Rank: 20 out of 403

308 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 308 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 308 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 4,371 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 382 268 1 4
LISINOPRIL 376 200 2 1
HYDROCHLOROTHIAZIDE 341 227 3 6
METFORMIN HCL 299 109 4 8
SIMVASTATIN 267 180 5 2
LEVOTHYROXINE SODIUM 246 104 6 3
ATORVASTATIN CALCIUM 237 77 7 5
CRESTOR 227 81 8 19
FUROSEMIDE 218 136 9 7
DIVALPROEX SODIUM 162 0 10 64
OMEPRAZOLE 150 70 11 9
RISPERIDONE 148 26 12 48
CARBAMAZEPINE 125 22 13 101
BENZTROPINE MESYLATE 121 0 R 14 143
PROPRANOLOL HCL 119 0 15 138
TOPIRAMATE 108 0 16 125
NEXIUM 106 22 17 18
ALENDRONATE SODIUM 93 49 18 26
GABAPENTIN 89 50 19 17
METOPROLOL TARTRATE 83 57 20 10
JANUVIA 81 50 21 44
CARVEDILOL 79 66 22 32
LITHIUM CARBONATE 79 0 22 218
FLOVENT HFA 79 49 22 218
WARFARIN SODIUM 78 40 25 12
PREDNISONE 78 50 25 34
SERTRALINE HCL 76 0 27 20
DIOVAN 75 28 28 24
OXYCONTIN 74 40 S2 29 63
CYMBALTA 74 40 29 43
CHLORHEXIDINE GLUCONATE 73 0 31 111
FLUTICASONE PROPIONATE 70 13 32 47
KLOR-CON M20 69 45 33 85
PROAIR HFA 68 30 34 40
PAROXETINE HCL 68 0 34 68
GLIPIZIDE XL 68 48 34 196
POTASSIUM CHLORIDE 67 30 37 37
LOVASTATIN 66 39 38 42
NASONEX 66 0 38 139
ADVAIR DISKUS 65 27 40 33
PANTOPRAZOLE SODIUM 65 27 40 30
CLOZAPINE 64 0 42 128
DOXAZOSIN MESYLATE 64 52 42 103
POLYETHYLENE GLYCOL 3350 58 0 44 60
CLOPIDOGREL 57 42 45 55
QUETIAPINE FUMARATE 56 0 46 52
OXYCODONE-ACETAMINOPHEN 53 22 S2 47 45
GLIPIZIDE ER 53 28 47 86
NIASPAN 52 0 49 142
METOPROLOL SUCCINATE 52 28 49 11
OXYBUTYNIN CHLORIDE 51 0 51 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.